Severity of illness, outcomes, and resource use in elderly cancer patients with deep venous thrombosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 6, Issue 3, 2000, Pages 175-178

  Escalante, C P ^a   Kurtin, D ^a   Rivera, E ^a   Elting, L S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Deep venous thrombosis; Elderly patients; Outcomes; Resource use; Severity of illness

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

AGE; AGED; ARTICLE; CANCER PATIENT; COST OF ILLNESS; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; HOSPITALIZATION; HUMAN; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0033841131     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960000600310     Document Type: Article

References (10)

1. Incidence of venous thromboembolism in medical and surgical patients
2. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study
3. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
4. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
5. Prevention of thromboembolism
6. The epidemiology of venous thrombosis
7. Clinical assessment of venous thromboembolic risk in surgical patients